COVID-19 Impact on Global Longevity and Anti-senescence Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: C05B1FEB56DAEN
QYResearch

Abstracts

This report focuses on the global Longevity and Anti-senescence Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Longevity and Anti-senescence Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• CohBar
• TA Sciences
• Unity Biotechnology
• AgeX Therapeutics?Inc
• PowerVision Inc.

Market segment by Type, the product can be split into

• Hemolytic Drug Therapy
• Gene Therapy
• Immunotherapy
• Other Stem Cell Therapies

Market segment by Application, split into

• Hospital
• Medical Service Institution
• Drug and Device Sales

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Longevity and Anti-senescence Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Longevity and Anti-senescence Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Longevity and Anti-senescence Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hemolytic Drug Therapy
  1.4.3 Gene Therapy
  1.4.4 Immunotherapy
  1.4.5 Other Stem Cell Therapies
1.5 Market by Application
  1.5.1 Global Longevity and Anti-senescence Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Medical Service Institution
  1.5.4 Drug and Device Sales
1.6 Coronavirus Disease 2019 (Covid-19): Longevity and Anti-senescence Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Longevity and Anti-senescence Therapy Industry
    1.6.1.1 Longevity and Anti-senescence Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Longevity and Anti-senescence Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Longevity and Anti-senescence Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Longevity and Anti-senescence Therapy Market Perspective (2015-2026)
2.2 Longevity and Anti-senescence Therapy Growth Trends by Regions
  2.2.1 Longevity and Anti-senescence Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Longevity and Anti-senescence Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Longevity and Anti-senescence Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Longevity and Anti-senescence Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Longevity and Anti-senescence Therapy Players by Market Size
  3.1.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue (2015-2020)
  3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Longevity and Anti-senescence Therapy Market Concentration Ratio
  3.2.1 Global Longevity and Anti-senescence Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Longevity and Anti-senescence Therapy Revenue in 2019
3.3 Longevity and Anti-senescence Therapy Key Players Head office and Area Served
3.4 Key Players Longevity and Anti-senescence Therapy Product Solution and Service
3.5 Date of Enter into Longevity and Anti-senescence Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Type (2015-2020)
4.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2021-2026)

5 LONGEVITY AND ANTI-SENESCENCE THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
5.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Longevity and Anti-senescence Therapy Market Size (2015-2020)
6.2 Longevity and Anti-senescence Therapy Key Players in North America (2019-2020)
6.3 North America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
6.4 North America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Longevity and Anti-senescence Therapy Market Size (2015-2020)
7.2 Longevity and Anti-senescence Therapy Key Players in Europe (2019-2020)
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
7.4 Europe Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Longevity and Anti-senescence Therapy Market Size (2015-2020)
8.2 Longevity and Anti-senescence Therapy Key Players in China (2019-2020)
8.3 China Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
8.4 China Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Longevity and Anti-senescence Therapy Market Size (2015-2020)
9.2 Longevity and Anti-senescence Therapy Key Players in Japan (2019-2020)
9.3 Japan Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
9.4 Japan Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Longevity and Anti-senescence Therapy Market Size (2015-2020)
10.2 Longevity and Anti-senescence Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Longevity and Anti-senescence Therapy Market Size (2015-2020)
11.2 Longevity and Anti-senescence Therapy Key Players in India (2019-2020)
11.3 India Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
11.4 India Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Longevity and Anti-senescence Therapy Market Size (2015-2020)
12.2 Longevity and Anti-senescence Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
12.4 Central & South America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 CohBar
  13.1.1 CohBar Company Details
  13.1.2 CohBar Business Overview and Its Total Revenue
  13.1.3 CohBar Longevity and Anti-senescence Therapy Introduction
  13.1.4 CohBar Revenue in Longevity and Anti-senescence Therapy Business (2015-2020))
  13.1.5 CohBar Recent Development
13.2 TA Sciences
  13.2.1 TA Sciences Company Details
  13.2.2 TA Sciences Business Overview and Its Total Revenue
  13.2.3 TA Sciences Longevity and Anti-senescence Therapy Introduction
  13.2.4 TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
  13.2.5 TA Sciences Recent Development
13.3 Unity Biotechnology
  13.3.1 Unity Biotechnology Company Details
  13.3.2 Unity Biotechnology Business Overview and Its Total Revenue
  13.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Introduction
  13.3.4 Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
  13.3.5 Unity Biotechnology Recent Development
13.4 AgeX Therapeutics?Inc
  13.4.1 AgeX Therapeutics?Inc Company Details
  13.4.2 AgeX Therapeutics?Inc Business Overview and Its Total Revenue
  13.4.3 AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Introduction
  13.4.4 AgeX Therapeutics?Inc Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
  13.4.5 AgeX Therapeutics?Inc Recent Development
13.5 PowerVision Inc.
  13.5.1 PowerVision Inc. Company Details
  13.5.2 PowerVision Inc. Business Overview and Its Total Revenue
  13.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Introduction
  13.5.4 PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
  13.5.5 PowerVision Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Longevity and Anti-senescence Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue
Table 3. Ranking of Global Top Longevity and Anti-senescence Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hemolytic Drug Therapy
Table 6. Key Players of Gene Therapy
Table 7. Key Players of Immunotherapy
Table 8. Key Players of Other Stem Cell Therapies
Table 9. COVID-19 Impact Global Market: (Four Longevity and Anti-senescence Therapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Longevity and Anti-senescence Therapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Longevity and Anti-senescence Therapy Players to Combat Covid-19 Impact
Table 14. Global Longevity and Anti-senescence Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Longevity and Anti-senescence Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Longevity and Anti-senescence Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Longevity and Anti-senescence Therapy Market Share by Regions (2015-2020)
Table 18. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Longevity and Anti-senescence Therapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Longevity and Anti-senescence Therapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Longevity and Anti-senescence Therapy Players
Table 25. Global Longevity and Anti-senescence Therapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Longevity and Anti-senescence Therapy Market Share by Players (2015-2020)
Table 27. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Longevity and Anti-senescence Therapy as of 2019)
Table 28. Global Longevity and Anti-senescence Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Longevity and Anti-senescence Therapy Product Solution and Service
Table 31. Date of Enter into Longevity and Anti-senescence Therapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Longevity and Anti-senescence Therapy Market Size Share by Type (2015-2020)
Table 35. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2021-2026)
Table 36. Global Longevity and Anti-senescence Therapy Market Size Share by Application (2015-2020)
Table 37. Global Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Longevity and Anti-senescence Therapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 41. North America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 43. North America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 47. Europe Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 49. Europe Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 51. China Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 53. China Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. China Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 55. China Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 59. Japan Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 61. Japan Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 65. Southeast Asia Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 67. Southeast Asia Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 69. India Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 70. India Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 71. India Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 72. India Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 73. India Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 74. India Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 77. Central & South America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 79. Central & South America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 81. CohBar Company Details
Table 82. CohBar Business Overview
Table 83. CohBar Product
Table 84. CohBar Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 85. CohBar Recent Development
Table 86. TA Sciences Company Details
Table 87. TA Sciences Business Overview
Table 88. TA Sciences Product
Table 89. TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 90. TA Sciences Recent Development
Table 91. Unity Biotechnology Company Details
Table 92. Unity Biotechnology Business Overview
Table 93. Unity Biotechnology Product
Table 94. Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 95. Unity Biotechnology Recent Development
Table 96. AgeX Therapeutics?Inc Company Details
Table 97. AgeX Therapeutics?Inc Business Overview
Table 98. AgeX Therapeutics?Inc Product
Table 99. AgeX Therapeutics?Inc Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 100. AgeX Therapeutics?Inc Recent Development
Table 101. PowerVision Inc. Company Details
Table 102. PowerVision Inc. Business Overview
Table 103. PowerVision Inc. Product
Table 104. PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 105. PowerVision Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Longevity and Anti-senescence Therapy Market Share by Type: 2020 VS 2026
Figure 2. Hemolytic Drug Therapy Features
Figure 3. Gene Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Other Stem Cell Therapies Features
Figure 6. Global Longevity and Anti-senescence Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Medical Service Institution Case Studies
Figure 9. Drug and Device Sales Case Studies
Figure 10. Longevity and Anti-senescence Therapy Report Years Considered
Figure 11. Global Longevity and Anti-senescence Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Longevity and Anti-senescence Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Longevity and Anti-senescence Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Longevity and Anti-senescence Therapy Market Share by Players in 2019
Figure 16. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Longevity and Anti-senescence Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Longevity and Anti-senescence Therapy Revenue in 2019
Figure 18. North America Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. CohBar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. CohBar Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 27. TA Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. TA Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 29. Unity Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Unity Biotechnology Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 31. AgeX Therapeutics?Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AgeX Therapeutics?Inc Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 33. PowerVision Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. PowerVision Inc. Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed